Clinical Trial Update: Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing denosumab vs zoledronic acid for bone mineral density in patients with idiopathic inflammatory myopathies and osteoporosis/oste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Inflammatory Myopathies
• Osteopenia
• Osteoporosis

Drugs mentioned

• Denosumab (denosumab)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Kwong Wah Hospital | Conditions: Idiopathic Inflammatory Myopathies, Osteoporosis, Osteopenia | Phase 3 | Status: UNKNOWN